Skip to search formSkip to main contentSkip to account menu

onabotulinumtoxinA

Known as: onabotulinum toxin A, onabotulinumtoxin A 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (2)

Botoxvistabel

Broader (1)

Botulinum Toxin Type A
onabotulinumtoxinA 200 UNT Injection

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
BackgroundOnabotulinumtoxinA is approved for the prevention of headache in those with chronic migraine (CM); however, more… 
Highly Cited
2018
Highly Cited
2018
OnabotulinumtoxinA in chronic migraine: predictors of response. A prospective multicentre descriptive study
OnabotulinumtoxinA is a treatment specifically approved for the prophylaxis of chronic migraine in adults. The aim of this study… 
Review
2017
Review
2017
Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta‐analysis
To compare the efficacy of onabotulinumtoxinA, mirabegron, and anticholinergics in adults with idiopathic overactive bladder (OAB… 
Highly Cited
2015
Highly Cited
2015
Pregnancy outcomes following exposure to onabotulinumtoxinA†
To evaluate pregnancy outcomes following onabotulinumtoxinA (US Food and Drug Administration pregnancy category C product… 
Highly Cited
2014
Highly Cited
2014
Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT
Objective The approved use of onabotulinumtoxinA for prophylaxis of headaches in patients with chronic migraine (CM) involves… 
Highly Cited
2014
Highly Cited
2014
OnabotulinumtoxinA for the treatment of a "gummy smile".
BACKGROUND Excessive gingival display, or a "gummy smile," is defined as 2 mm or more of gingival exposure upon smiling. Such… 
Highly Cited
2013
Highly Cited
2013
OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial
Highly Cited
2011
Highly Cited
2011
Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxina in a randomized, placebo‐controlled dose‐finding study in idiopathic overactive bladder
We assessed the effects of onabotulinumtoxinA (BOTOX®) on clinical and urodynamic variables in patients with idiopathic… 
Highly Cited
2010
Highly Cited
2010
Meta‐analysis of neutralizing antibody conversion with onabotulinumtoxinA (BOTOX®) across multiple indications
This meta‐analysis evaluated the frequency of neutralizing antibody (nAb) conversion with onabotulinumtoxinA (BOTOX®; Allergan… 
Highly Cited
2009
Highly Cited
2009
A Double‐Blind Comparison of OnabotulinumtoxinA (BOTOX®) and Topiramate (TOPAMAX®) for the Prophylactic Treatment of Chronic Migraine: A Pilot Study
Background.— There is a need for effective prophylactic therapy for chronic migraine (CM) that has minimal side effects. 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)